menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Identifying and Managing Patients with IBD at Risk for Progressive Disease

IBD is a chronic gastrointestinal condition characterized by recurring disease activity. Treatment approaches for IBD vary depending on disease typ...

Available credits: 1.00

Time to complete: 1 hour

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    IBD is a chronic gastrointestinal condition characterized by recurring disease activity. Treatment approaches for IBD vary depending on disease type and severity and patient risk profile. An accurate diagnosis combined with severity and risk assessments at appropriate intervals are essential for optimal management of IBD. Despite guidance from AGA and ACG, however, clinicians demonstrate considerable variation in their approaches to both risk assessment and care for patients with IBD. This activity will address severity and risk assessment, appropriate treatment, and patient communication.

  • Learning Objectives

    Upon completion of this educational activity, the participant should be able to:

    1. Review the approaches to risk and severity assessment for patients with IBD, as it relates to treatment decision making.
    2. Discuss the treatment strategies for the management of patients with high-risk IBD, including the benefits and safety profile of biologic therapy.
    3. Discuss the guideline recommendations and quality measures related to preventative care and screening needs in patients with IBD.
    4. Describe practical approaches to patient engagement to optimize shared treatment decision-making.
  • Target Audience

    Gastroenterologists and other clinicians involved in the management of patients with IBD including nurse practitioners (NPs), physician assistants (PAs), and nurses.

  • Disclosure of Conflicts of Interest

    The “Conflict of Interest Disclosure Policies” of Albert Einstein College of Medicine require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

    The Albert Einstein College of Medicine also require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

    Contributors whose COIs are irresolvable are not permitted to participate in Einstein CME activities.

    FACULTY DISCLOSURES
    William J. Sandborn, MD
    Consultant: AbbVie, Amgen, Celgene, Genentech, Janssen, MedImmune, Pfizer, Takeda, UCB Pharma
    Speakers Bureau: Janssen
    Contracted Research: AbbVie, Amgen, Celgene, Genentech, Janssen, Pfizer, Takeda  

    Lawrence J. Brandt, MD (CCME reviewer)
    Nothing to disclose.

    The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with any commercial interests relative to this CME activity. 
    Donald Harting, Writer/Editor, MCM Education, has no conflicts of interest to disclose.
    Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.
    Terry Ann Glauser, MD, MPH, Vice President, Medical Affairs, MCM Education, has no conflicts of interest to disclose.

  • Accreditation and Credit Designation Statements

    ACCME ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Albert Einstein College of Medicine, Montefiore Medical Center, and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    ACCME CREDIT DESIGNATION STATEMENT: Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

        

  • Commercial Support

    This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

  • Disclaimer

    Presented by Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, and MCM Education.

    The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, or Takeda Pharmaceuticals U.S.A., Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.